ATP8A2 inhibitors represent a class of chemical compounds specifically designed to target and inhibit the activity of the ATP8A2 protein. ATP8A2, also known as ATPase phospholipid transporting 8A2, is a transmembrane protein that plays a crucial role in the maintenance of cellular membrane integrity and lipid asymmetry. It is primarily localized in the endoplasmic reticulum (ER) and is responsible for the active transport of phospholipids from the outer to the inner leaflet of the ER membrane. This activity is essential for various cellular processes, including membrane repair, signal transduction, and maintaining the structural integrity of organelles. ATP8A2 inhibitors, as their name suggests, are compounds that interfere with the normal function of ATP8A2 by binding to it and preventing its phospholipid transport activity.
ATP8A2 has garnered significant interest in the field of cell biology and membrane biology due to its potential implications for understanding cellular membrane dynamics. Researchers have been working on identifying and characterizing ATP8A2 inhibitors to explore their effects on cellular processes and elucidate the role of ATP8A2 in various physiological contexts. These inhibitors are valuable tools for studying the consequences of disrupting phospholipid transport and membrane asymmetry, shedding light on fundamental cellular mechanisms and potentially offering insights into the pathogenesis of diseases associated with membrane dysfunction. Overall, ATP8A2 inhibitors represent a promising avenue for scientific exploration, with the potential to advance our understanding of cellular membrane biology.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Propranolol | 525-66-6 | sc-507425 | 100 mg | $180.00 | ||
A non-selective beta-blocker that can alter cellular signaling pathways, possibly affecting ATP8A2 activity by modulating the cellular environment where ATP8A2 functions. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
A calcium channel blocker that may indirectly influence ATP8A2 by altering calcium-dependent signaling and membrane dynamics. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
An isoflavone that acts as a tyrosine kinase inhibitor, potentially altering signaling pathways that regulate ATP8A2. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
A flavonoid that can modulate multiple signaling pathways, possibly impacting ATP8A2 function through indirect mechanisms. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
A farnesyltransferase inhibitor that can alter Ras signaling, possibly affecting ATP8A2's role in cell signaling. | ||||||
Cerulenin (synthetic) | 17397-89-6 | sc-200827 sc-200827A sc-200827B | 5 mg 10 mg 50 mg | $161.00 $312.00 $1210.00 | 9 | |
An inhibitor of fatty acid synthase that may disrupt lipid metabolism, thereby potentially influencing ATP8A2's activity. | ||||||
Perifosine | 157716-52-4 | sc-364571 sc-364571A | 5 mg 10 mg | $188.00 $327.00 | 1 | |
An alkylphospholipid that can modulate Akt signaling, potentially affecting the phospholipid environment of ATP8A2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that may alter phosphoinositide signaling, potentially impacting ATP8A2's function indirectly. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $203.00 $611.00 | 24 | |
An inhibitor of neutral sphingomyelinase that may alter ceramide signaling, indirectly affecting ATP8A2's activity. | ||||||
D609 | 83373-60-8 | sc-201403 sc-201403A | 5 mg 25 mg | $189.00 $575.00 | 7 | |
A phosphatidylcholine-specific phospholipase C inhibitor that could influence ATP8A2 by modulating phospholipid metabolism. | ||||||